Skip to main content
| Hans-Günter Meyer-Thompson | Fachveröffentlichungen

Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis 

Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis 

Hsu T, Tsai C, Kao Y, Thompson T, Carvalho A F, Yang F et al. 

BMJ 2024; 386 :e078607 doi:10.1136/bmj-2023-078607 

https://www.bmj.com/content/386/bmj-2023-078607